ADAM10 and neoplasm: GEPDX ALL-199 and ALL-265 cells with and without ADAM10 KO were mixed at a 1:1 ratio and injected into groups of mice in serial dilutions, and tumor engraftment was analyzed after eight weeks by flow cytometry.